AOR
Archives of Ophthalmological Research

The Archives of Ophthalmological Research aims to publish issues related to publish articles of the highest scientific and clinical value at an international level, and accepts articles on these topics. The target audience of the journal included specialists and physicians working in ophthalmology, and other health professionals interested in these fields.

eISSN: 3023-6479
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Case Report
Co-Existence of multiple sclerosis and vitiligo in a patient with epithelial map-dot-fingerprint dystrophy
Abstract
Multiple sclerosis is a chronic demyelinating central nervous system disease that manifests itself with muscle weakness, sensory disturbances and numbness in the extremities, impaired balance, gait, speech, blurred vision and diplopia seen in attacks. A 41-year-old female patient referred to us with the sudden complaints of blurred vision and diplopia in the right gaze. She had been following up with the diagnosis of recurrent corneal erosions and epithelial basement membrane dystrophy in the ophthalmology department for the last three years. In cranial magnetic resonance imaging, there were hyperintense lesions in the bilateral periventricular white matter, which was remarkable in the right hemisphere in T2W scan. She also had acrocephalic vitiligo and multinodular goiter for years. HLA-A2, DRB1*0407, DRB1*1301, DQB1*0301, DQB1*0603 haplotypes were detected. Both autoimmunity and genetic factors may play a role in the co-existence of Multiple sclerosis and vitiligo.

Keywords : Autoimmunity, corneal dystrophy, epithelial basement membrane, HLA antigens, multiple sclerosis, vitiligo

Download Article


1. Dobson R, Giovannoni G. Multiple sclerosis: a review. Eur J Neurol. 2019;26(1):27-40. doi:10.1111/ene.13819
2. Lublin FD, Reingold SC, Cohen JA, et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 2014;83(3):278-286. doi:10.1212/WNL.0000000000000560
3. Sahraian MA, Owji M, Naser Moghadasi A. Concomitant multiple sclerosis and another autoimmune disease: does the clinical course change? Clin Neurol Neurosurg. 2016;150:92-95. doi:10.1016/j.clineuro.2016.08.027
4. Barcellos LF, Kamdar BB, Ramsay PP, et al. Clustering of autoimmune diseases in families with a high risk of multiple sclerosis: a descriptive study. Lancet Neurol. 2006;5(11):924-931. doi:10.1016/S1474-4422(06)70581-5
5. Dobson R, Giovannoni G. Autoimmune disease in people with multiple sclerosis and their relatives: a systematic review and meta-analysis. J Neurol. 2013;260(5):1272-1285. doi:10.1007/s00415-012-6790-1
6. Cojocaru M, Cojocaru IM, Silosi I. Multiple autoimmune syndrome. Maedica (Bucur). 2010;5(2):132-134.
7. Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018; 17(2):162-173. doi:10.1016/S1474-4422(17)30470-2
8. Brown N, Bron A. Recurrent erosion of the cornea. Br J Ophthalmol. 1976;60(2):84-96. doi:10.1136/bjo.60.2.84
9. Bron AJ, Tripathi RC. Cystic disorders of the corneal epithelium. I. Clinical aspects. Br J Ophthalmol. 1973;57(6):361-375. doi:10.1136/bjo.57.6.361
10. Weiss JS, Møller HU, Aldave AJ, et al. IC3D classification of corneal dystrophies-edition 2. Cornea. 2015;34(2):117-159. doi:10.1097/ICO.0000000000000307
11. Roshanisefat H, Bahmanyar S, Hillert J, Olsson T, Montgomery S. Shared genetic factors may not explain the raised risk of comorbid inflammatory diseases in multiple sclerosis. Mult Scler. 2012;18(10):1430-1436. doi:10.1177/1352458512438234
12. Deretzi G, Kountouras J, Polyzos SA, et al. Polyautoimmunity in a Greek cohort of multiple sclerosis. Acta Neurol Scand. 2015;131(4):225-230. doi:10.1111/ane.12331
13. Gill L, Zarbo A, Isedeh P, Jacobsen G, Lim HW, Hamzavi I. Comorbid autoimmune diseases in patients with vitiligo: a cross-sectional study. J Am Acad Dermatol. 2016;74(2):295-302. doi:10.1016/j.jaad.2015.08.063
14. Hadi A, Wang JF, Uppal P, Penn LA, Elbuluk N. Comorbid diseases of vitiligo: a 10-year cross-sectional retrospective study of an urban US population. J Am Acad Dermatol. 2020;82(3):628-633. doi:10.1016/j.jaad.2019.08.063
15. Shen MH, Ng CY, Chang KH, Chi CC. Association of multiple sclerosis with vitiligo: a systematic review and meta-analysis. Sci Rep. 2020;10(1): 17792. doi:10.1038/s41598-020-74945-3
16. Maghbooli Z, Sahraian MA, Naser Moghadasi A. Multiple sclerosis and human leukocyte antigen genotypes: focus on the Middle East and North Africa region. Mult Scler J Exp Transl Clin. 2020;6(1):2055217319881775. doi:10.1177/2055217319881775
17. Liu JB, Li M, Chen H, et al. Association of vitiligo with HLA-A2: a meta-analysis. J Eur Acad Dermatol Venereol. 2007;21(2):205-213. doi:10.1111/j.1468-3083.2006.01953.x
Article available in :
Volume 3, Issue 2, 2026
Page : 34-37
https://doi.org/10.51271/AOR-0052
Article Information
Received : 28 May 2026
Accepted : 29 Haz 2026
Published : 30 Haz 2026
Corresponding Author :

Serhat Eker: Department of Ophthalmology, Faculty of Medicine, Selçuk University, Konya, Turkiye

[email protected]
Citation : Eker S, Bozkurt B, Ekmekçi H, Eren F. Co-existence of multiple sclerosis and vitiligo in a patient with epithelial map-dotfingerprint dystrophy. Arch Ophthalmol Res. 2026;3(2):34-37.

Read: 55
Download : 49
Cited: 0
_Footer